Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Ropivacaine HCl

Client Email

Product

Ropivacaine HCl
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Ropivacaine HCl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 16 USDMF, 9 CEP/COS, 1 JDMF, 12 EU WC, 5 KDMF, 12 NDC API, 38 Listed Suppliers, $ API Reference Price

53 API Suppliers
16 USDMF
9 CEP/COS
1 JDMF
12 EU WC
5 KDMF
12 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

12 API Suppliers

12 API Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 75 FDA Orange Book, 48 Europe, 6 Canada, 11 South Africa, 22 Listed Dossiers

162 FDF Dossiers
75 FDA Orange Book
48 Europe
6 Canada
11 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - 100MG/10ML (10MG/ML), SOLUTION;INJECTION - 100MG/20ML (5MG/ML), SOLUTION;INJECTION - 150MG/30ML (5MG/ML), SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML), SOLUTION;INJECTION - 1GM/200ML (5MG/ML), SOLUTION;INJECTION - 200MG/20ML (10MG/ML), SOLUTION;INJECTION - 200MG/100ML (2MG/ML), SOLUTION;INJECTION - 20MG/10ML (2MG/ML), SOLUTION;INJECTION - 400MG/200ML (2MG/ML), SOLUTION;INJECTION - 40MG/20ML (2MG/ML), SOLUTION;INJECTION - 500MG/100ML (5MG/ML), SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INJECTION - 100MG/10ML (10MG/ML)
SOLUTION;INJECTION - 100MG/20ML (5MG/ML)
SOLUTION;INJECTION - 150MG/30ML (5MG/ML)
SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)
SOLUTION;INJECTION - 1GM/200ML (5MG/ML)
SOLUTION;INJECTION - 200MG/20ML (10MG/ML)
SOLUTION;INJECTION - 200MG/100ML (2MG/ML)
SOLUTION;INJECTION - 20MG/10ML (2MG/ML)
SOLUTION;INJECTION - 400MG/200ML (2MG/ML)
SOLUTION;INJECTION - 40MG/20ML (2MG/ML)
SOLUTION;INJECTION - 500MG/100ML (5MG/ML)
SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Actylis

3 Actylis

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices

1 US Medicaid Prescriptions
25 Finished Drug Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 14 Health Canada Patents

6 US Patents
14 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 15 Others

3 EDQM
3 USP
15 Others

$ API Ref.Price (USD/KG) : 1,355 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6FRESENIUS KABI USA

filter Patent Number Reset all filters

6 All

01 27828787

02 27857802

03 28162915

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 6Y

filter Expiration Date Reset all filters

6 All

01 22024-05-23

02 22025-10-18

03 22026-11-28

Chemwerth Ropivacaine HCl

US Patents
Health Canada Patents

Product Main Page

01

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-28

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-23

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 8162915

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-23

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 8162915

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-18

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-18

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7828787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

FRESENIUS KABI USA

ROPIVACAINE HYDROCHLORIDE

Luxepack

Not Confirmed

FRESENIUS KABI USA

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-28

ROPIVACAINE HYDROCHLORIDE

US Patent Number : 7857802

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 20533

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?